Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women.

Cholesterol Pub Date : 2014-01-01 Epub Date: 2014-11-18 DOI:10.1155/2014/720507
Amanda L Zaleski, Marianne L Mentch, Linda S Pescatello, Beth A Taylor, Jeffrey A Capizzi, Adam S Grimaldi, Priscilla M Clarkson, Stephanie A Moeckel-Cole, Stuart R Chipkin, Justin Keadle, Charles Michael White, Paul D Thompson
{"title":"Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women.","authors":"Amanda L Zaleski,&nbsp;Marianne L Mentch,&nbsp;Linda S Pescatello,&nbsp;Beth A Taylor,&nbsp;Jeffrey A Capizzi,&nbsp;Adam S Grimaldi,&nbsp;Priscilla M Clarkson,&nbsp;Stephanie A Moeckel-Cole,&nbsp;Stuart R Chipkin,&nbsp;Justin Keadle,&nbsp;Charles Michael White,&nbsp;Paul D Thompson","doi":"10.1155/2014/720507","DOIUrl":null,"url":null,"abstract":"<p><p>Statins are the most widely prescribed and effective medication for reducing low density lipoprotein cholesterol. Statins may also lower resting blood pressure (BP); however, results are inconsistent. We sought to determine if the maximum dose of atorvastatin reduces resting BP and the peak systolic BP (SBP) achieved on a graded exercise stress test (GEST) among a large sample of 419 healthy men (48%) and women (52%). Subjects (419, 44.1 ± 0.8 yr) were double-blinded and randomized to 80 mg·d(-1) of atorvastatin (n = 202) or placebo (n = 217) for 6 mo. Among the total sample, there were no differences in resting BP (SBP, P = 0.30; diastolic BP [DBP], P = 0.69; mean arterial pressure (P = 0.76); or peak SBP on a GEST (P = 0.99)) over 6 mo, regardless of drug treatment group. However, among women on atorvastatin, resting SBP/DBP (3.7±1.5 mmHg, P = 0.01/3.2±0.9 mmHg, P = 0.02) and peak SBP on a GEST (6.5±1.5 mmHg, P = 0.04) were lower versus men. Atorvastatin lowered resting BP 3-4 mmHg and peak SBP on a GEST ~7 mmHg more among women than men over 6 mo of treatment. The inconsistent findings regarding the antihypertensive effects of statins may be partially explained by not accounting for sex effects. </p>","PeriodicalId":72589,"journal":{"name":"Cholesterol","volume":"2014 ","pages":"720507"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/720507","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cholesterol","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/720507","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/11/18 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Statins are the most widely prescribed and effective medication for reducing low density lipoprotein cholesterol. Statins may also lower resting blood pressure (BP); however, results are inconsistent. We sought to determine if the maximum dose of atorvastatin reduces resting BP and the peak systolic BP (SBP) achieved on a graded exercise stress test (GEST) among a large sample of 419 healthy men (48%) and women (52%). Subjects (419, 44.1 ± 0.8 yr) were double-blinded and randomized to 80 mg·d(-1) of atorvastatin (n = 202) or placebo (n = 217) for 6 mo. Among the total sample, there were no differences in resting BP (SBP, P = 0.30; diastolic BP [DBP], P = 0.69; mean arterial pressure (P = 0.76); or peak SBP on a GEST (P = 0.99)) over 6 mo, regardless of drug treatment group. However, among women on atorvastatin, resting SBP/DBP (3.7±1.5 mmHg, P = 0.01/3.2±0.9 mmHg, P = 0.02) and peak SBP on a GEST (6.5±1.5 mmHg, P = 0.04) were lower versus men. Atorvastatin lowered resting BP 3-4 mmHg and peak SBP on a GEST ~7 mmHg more among women than men over 6 mo of treatment. The inconsistent findings regarding the antihypertensive effects of statins may be partially explained by not accounting for sex effects.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿托伐他汀对正常血压男女静息和运动峰值血压的影响。
他汀类药物是用于降低低密度脂蛋白胆固醇的最广泛和有效的药物。他汀类药物也可以降低静息血压(BP);然而,结果并不一致。在419名健康男性(48%)和女性(52%)的大样本中,我们试图确定阿托伐他汀的最大剂量是否会降低静息血压和在分级运动应激试验(GEST)中达到的峰值收缩压(SBP)。研究对象(419名,44.1±0.8岁)采用双盲法,随机接受80mg·d(-1)阿托伐他汀(n = 202)或安慰剂(n = 217)治疗6个月。两组间静息血压差异无统计学意义(SBP, P = 0.30;舒张压[DBP], P = 0.69;平均动脉压(P = 0.76);(P = 0.99))超过6个月,与药物治疗组无关。然而,在服用阿托伐他汀的女性中,静息收缩压/舒张压(3.7±1.5 mmHg, P = 0.01/3.2±0.9 mmHg, P = 0.02)和est收缩压峰值(6.5±1.5 mmHg, P = 0.04)低于男性。阿托伐他汀治疗6个月期间,女性比男性更能降低静息血压3-4毫米汞柱,在est时降低收缩压峰值7毫米汞柱。关于他汀类药物抗高血压作用的不一致的发现可能部分解释为没有考虑到性别影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Impact of Egg Nutrient Composition and Its Consumption on Cholesterol Homeostasis. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Association between HDL Cholesterol Levels and the Consumption of Vitamin A in Metabolically Healthy Obese Lebanese: A Cross-Sectional Study among Adults in Lebanon. Cereal-Based Snack Bar with Added Plant Stanol Ester (Benecol®) Consumed between Meals Lowers Serum Total and LDL Cholesterol Effectively in Mildly to Moderately Hypercholesterolemic Subjects. Effect of Anthocyanin Supplementations on Lipid Profile and Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1